Medicina
Departamento
JORGE BENITO
CANNATA ANDIA
Investigador ata 2022
Publicacións nas que colabora con JORGE BENITO CANNATA ANDIA (400)
2024
-
Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients
Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626
-
Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2023
-
Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure
Nutrients, Vol. 15, Núm. 8
-
Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities
International Journal of Molecular Sciences, Vol. 24, Núm. 12
-
Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
Antioxidants, Vol. 12, Núm. 2
-
MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740
-
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597
-
Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145
Nutrients, Vol. 15, Núm. 13
-
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
Nefrologia, Vol. 43, pp. 1-36
-
Redox Metabolism and Vascular Calcification in Chronic Kidney Disease
Biomolecules, Vol. 13, Núm. 9
-
Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
International journal of molecular sciences, Vol. 24, Núm. 6
-
Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
Nutrients, Vol. 15, Núm. 6
2022
-
A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial
BMC medicine, Vol. 20, Núm. 1, pp. 83
-
Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges
Kidney International, Vol. 102, Núm. 2, pp. 431-434
-
Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12
-
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia
Nature Reviews Endocrinology, Vol. 18, Núm. 6, pp. 366-384
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)
Nefrologia, Vol. 42, pp. 1-37
-
Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study
Nefrologia, Vol. 42, Núm. 5, pp. 594-606
-
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism
Nutrients, Vol. 14, Núm. 9